Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
NCT00972127
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Neramexane
Sponsor
Merz Pharmaceuticals GmbH